TransMedics Group (TMDX) Competitors

$137.98
+3.05 (+2.26%)
(As of 05/17/2024 ET)

TMDX vs. ITGR, LIVN, MASI, CNMD, INMD, SLNO, NUVL, DOCS, IMVT, and SEM

Should you be buying TransMedics Group stock or one of its competitors? The main competitors of TransMedics Group include Integer (ITGR), LivaNova (LIVN), Masimo (MASI), CONMED (CNMD), InMode (INMD), Soleno Therapeutics (SLNO), Nuvalent (NUVL), Doximity (DOCS), Immunovant (IMVT), and Select Medical (SEM). These companies are all part of the "medical" sector.

TransMedics Group vs.

TransMedics Group (NASDAQ:TMDX) and Integer (NYSE:ITGR) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, community ranking, media sentiment, dividends, valuation, analyst recommendations and profitability.

Integer has a net margin of 6.01% compared to TransMedics Group's net margin of -3.43%. Integer's return on equity of 11.25% beat TransMedics Group's return on equity.

Company Net Margins Return on Equity Return on Assets
TransMedics Group-3.43% 7.95% 1.61%
Integer 6.01%11.25%5.69%

In the previous week, Integer had 9 more articles in the media than TransMedics Group. MarketBeat recorded 18 mentions for Integer and 9 mentions for TransMedics Group. TransMedics Group's average media sentiment score of 0.78 beat Integer's score of 0.65 indicating that TransMedics Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TransMedics Group
5 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Integer
7 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

TransMedics Group presently has a consensus target price of $119.00, suggesting a potential downside of 13.76%. Integer has a consensus target price of $128.67, suggesting a potential upside of 6.41%. Given Integer's higher possible upside, analysts plainly believe Integer is more favorable than TransMedics Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TransMedics Group
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88
Integer
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

TransMedics Group has a beta of 1.87, suggesting that its share price is 87% more volatile than the S&P 500. Comparatively, Integer has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500.

Integer received 290 more outperform votes than TransMedics Group when rated by MarketBeat users. Likewise, 63.51% of users gave Integer an outperform vote while only 54.78% of users gave TransMedics Group an outperform vote.

CompanyUnderperformOutperform
TransMedics GroupOutperform Votes
86
54.78%
Underperform Votes
71
45.22%
IntegerOutperform Votes
376
63.51%
Underperform Votes
216
36.49%

Integer has higher revenue and earnings than TransMedics Group. TransMedics Group is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TransMedics Group$241.62M18.81-$25.03M-$0.34-405.82
Integer$1.60B2.54$90.65M$2.8941.84

99.7% of TransMedics Group shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 7.0% of TransMedics Group shares are owned by insiders. Comparatively, 2.0% of Integer shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Integer beats TransMedics Group on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TMDX vs. The Competition

MetricTransMedics GroupElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$4.54B$3.49B$5.24B$7.99B
Dividend YieldN/A1.66%44.24%3.91%
P/E Ratio-405.827.27100.5014.80
Price / Sales18.8165.272,370.7280.86
Price / Cash969.3769.8036.7931.98
Price / Book28.514.415.494.64
Net Income-$25.03M$87.99M$105.95M$217.28M
7 Day Performance6.15%1.47%1.42%2.90%
1 Month Performance63.95%1.28%4.96%6.66%
1 Year Performance90.47%1.92%7.84%9.89%

TransMedics Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ITGR
Integer
2.6607 of 5 stars
$112.00
-0.6%
$127.00
+13.4%
+50.0%$3.75B$1.60B38.7510,500Analyst Forecast
Short Interest ↑
LIVN
LivaNova
1.459 of 5 stars
$61.43
+0.5%
$66.20
+7.8%
+37.4%$3.33B$1.19B-102.382,900Short Interest ↓
Positive News
MASI
Masimo
4.7057 of 5 stars
$115.24
-0.8%
$138.71
+20.4%
-24.0%$6.12B$2.05B78.395,200
CNMD
CONMED
4.9926 of 5 stars
$72.47
-0.5%
$107.86
+48.8%
-37.2%$2.23B$1.24B27.774,000Short Interest ↓
INMD
InMode
2.8915 of 5 stars
$18.58
+0.5%
$32.80
+76.5%
-44.4%$1.56B$492.05M8.81581Short Interest ↑
News Coverage
SLNO
Soleno Therapeutics
3.9662 of 5 stars
$43.50
+1.6%
$60.33
+38.7%
+955.1%$1.45BN/A-16.2333
NUVL
Nuvalent
2.9404 of 5 stars
$68.02
+2.9%
$90.78
+33.5%
+82.1%$4.36BN/A-28.2292Analyst Forecast
Insider Selling
News Coverage
DOCS
Doximity
2.9702 of 5 stars
$23.51
+2.3%
$28.82
+22.6%
-15.9%$4.38B$419.05M35.61977Analyst Forecast
Options Volume
News Coverage
Gap Up
IMVT
Immunovant
1.7607 of 5 stars
$30.48
+2.0%
$48.00
+57.5%
+44.6%$4.43BN/A-16.57164Short Interest ↑
SEM
Select Medical
4.7615 of 5 stars
$34.08
+1.1%
$34.25
+0.5%
+19.0%$4.43B$6.66B16.2354,600Analyst Revision

Related Companies and Tools

This page (NASDAQ:TMDX) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners